Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ROMOSOZUMAB-AQQG Cause Wrong technique in product usage process? 109 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 109 reports of Wrong technique in product usage process have been filed in association with ROMOSOZUMAB-AQQG. This represents 1.0% of all adverse event reports for ROMOSOZUMAB-AQQG.

109
Reports of Wrong technique in product usage process with ROMOSOZUMAB-AQQG
1.0%
of all ROMOSOZUMAB-AQQG reports
0
Deaths
3
Hospitalizations

How Dangerous Is Wrong technique in product usage process From ROMOSOZUMAB-AQQG?

Of the 109 reports, 3 (2.8%) required hospitalization.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ROMOSOZUMAB-AQQG. However, 109 reports have been filed with the FAERS database.

What Other Side Effects Does ROMOSOZUMAB-AQQG Cause?

Fall (646) Fracture (612) Arthralgia (517) Injection site pain (490) Bone density abnormal (454) Off label use (419) Hospitalisation (381) Headache (360) Product storage error (348) Death (263)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which ROMOSOZUMAB-AQQG Alternatives Have Lower Wrong technique in product usage process Risk?

ROMOSOZUMAB-AQQG vs ROPEGINTERFERON ALFA-2B-NJFT ROMOSOZUMAB-AQQG vs ROPINIROLE ROMOSOZUMAB-AQQG vs ROPIVACAINE ROMOSOZUMAB-AQQG vs ROSIGLITAZONE ROMOSOZUMAB-AQQG vs ROSUVASTATIN

Related Pages

ROMOSOZUMAB-AQQG Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process ROMOSOZUMAB-AQQG Demographics